We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,822
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
TJX Companies
TJX
$176B
| $25.4M | 0.13% |
385,168
+35,049
| +10% | +$2.45M |
|
177
Citigroup
C
$233B
| $25.2M | 0.13% |
359,026
+42,926
| +14% | +$3M |
|
178
American Express
AXP
$235B
| $25.2M | 0.13% |
150,372
+4,693
| +3% | +$785K |
|
179
iShares Core S&P Mid-Cap ETF
IJH
$126B
| $24.6M | 0.13% |
468,090
+96,305
| +26% | +$5.18M |
|
180
Carter's
CRI
$1.44B
| $24.6M | 0.13% |
253,181
-635
| -0.3% | -$64.1K |
|
181
Wells Fargo
WFC
$271B
| $24.5M | 0.13% |
527,711
+13,648
| +3% | +$632K |
|
182
Analog Devices
ADI
$184B
| $24.2M | 0.13% |
144,758
+34,641
| +31% | +$5.81M |
|
|
SRCL
183
DELISTED
Stericycle Inc
SRCL
| $24M | 0.13% |
352,545
+38,114
| +12% | +$2.63M |
|
184
Aaon
AAON
$7.86B
| $23.8M | 0.13% |
547,080
+744
| +0.1% | +$32.3K |
|
185
iShares Russell 2000 Value ETF
IWN
$14.6B
| $23.6M | 0.12% |
147,054
+5,378
| +4% | +$864K |
|
|
TPIC
186
DELISTED
TPI Composites
TPIC
| $23.6M | 0.12% |
698,118
-40,377
| -5% | -$1.59M |
|
187
iShares MBS ETF
MBB
$39.1B
| $23.5M | 0.12% |
217,213
-55,795
| -20% | -$6.05M |
|
|
DOCU
188
DocuSign
DOCU
$10.9B
| $23.4M | 0.12% |
90,787
-14,801
| -14% | -$4.26M |
|
189
Dover
DOV
$28.5B
| $23.4M | 0.12% |
150,222
+10,793
| +8% | +$1.79M |
|
190
Vanguard Total International Stock ETF
VXUS
$159B
| $23M | 0.12% |
363,218
-2,050
| -0.6% | -$134K |
|
191
iShares Core MSCI Total International Stock ETF
IXUS
$59.9B
| $22.8M | 0.12% |
321,094
+20,776
| +7% | +$1.51M |
|
|
NVO
192
Novo Nordisk
NVO
$199B
| $22.8M | 0.12% |
474,674
+37,350
| +9% | +$1.81M |
|
193
Array Technologies
ARRY
$871M
| $22.6M | 0.12% |
1,222,215
-71,181
| -6% | -$1.18M |
|
|
FITB
194
Fifth Third Bancorp
FITB
$52.6B
| $22.4M | 0.12% |
528,484
+30,327
| +6% | +$1.16M |
|
195
Carnival Corporation Ltd
CCL
$40.7B
| $22.2M | 0.12% |
889,252
-39,359
| -4% | -$916K |
|
196
iShares S&P 500 Growth ETF
IVW
$77.4B
| $22.2M | 0.12% |
299,810
+11,702
| +4% | +$892K |
|
197
State Street Industrial Select Sector SPDR ETF
XLI
$34B
| $21.8M | 0.11% |
222,424
+1,424
| +0.6% | +$146K |
|
198
Chubb
CB
$135B
| $21.7M | 0.11% |
125,071
+1,937
| +2% | +$340K |
|
199
Berkshire Hathaway Class A
BRK.A
$1.11T
| $21.4M | 0.11% |
52
+1
| +2% | +$423K |
|
200
iShares S&P 500 Value ETF
IVE
$49.8B
| $21.4M | 0.11% |
147,008
-15,791
| -10% | -$2.35M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,822 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.